15 August 2025 - Vabysmo now covered across all three approved indications in the province, providing patients with a comprehensively funded option for their needs.

Roche Canada is pleased to announce today that Vabysmo (faricimab injection) is now publicly funded for macular oedema secondary to retinal vein occlusion on the Régie de l'assurance maladie du Québec (RAMQ) list of medications.

Read Roche press release